Abstract
Introduction
Antimicrobial resistance to carbapenems in Morganella morganii is emerging globally.
Materials and methods
Sixty isolates from freshwater fish, four from pig organs and 25 clinical patient isolates were included in the study. Freshwater fish and pork from wet markets in all districts in Hong Kong were obtained in April 2018 and January 2019. Food samples were inoculated to selective agars to look for Morganella morganii. Clinical isolates of M. morganii from three hospitals in Hong Kong were included in 2018–2022. Phenotypic antibiotic susceptibility testing was done by CLSI disc diffusion method. Whole-genome sequencing was performed to establish the antibiotic resistance gene (ARG) profile and phylogenetic relationship.
Results
Phenotypic resistance to fluoroquinolones was significantly higher for animal isolates than human isolates whereas that of aminoglycosides was significantly higher in human isolates. There was no significant difference in other tested antibiotics. There was no significant difference in ARG distribution between human and non-human isolates. Phylogenetically, 12 clinical isolates were clustered with corresponding freshwater fish isolates.
Conclusion
M. morganii isolates that caused human infections were phylogenetically related to those found in freshwater fish in wet markets. There was significant overlap between antimicrobial resistance genes in major antibiotic classes across isolates from humans and isolates from fish.
Introduction
Morganella morganii is a motile, non-lactose fermenting, facultative anaerobic Gram-negative bacillus that belongs to the Proteae tribe in the order Enterobacterales. It is characterized by the presence of inducible chromosomal AmpC and intrinsic resistance to multiple classes of antibiotics. The most common infections it causes are skin and soft tissue infections, genitourinary and intra-abdominal infections, affecting particularly patients with medical comorbidities.1–3 Previous studies have shown a high 30-day mortality that ranged from 21.2% to 51.7% among bacteraemic patients.1,3 There is also global concern on the emergence of extensively resistant M. morganii which could carry carbapenemases such as NDM-1, KPC-2, OXA-48 and IMP-1.4–9
The incidence of M. morganii bloodstream infections was estimated at 9.2 cases per million population and rising in an Australian study.2
Apart from in humans, M. morganii is also found in the environment. It was shown to be residing within free-living amoeba in the environment, with a potential to carry antimicrobial resistance.10 From a One Health perspective, the convergence of antimicrobial resistance from food animals in human is of significant concern.11 Given the emerging concern with multidrug-resistant M. morganii, a One Health approach would be useful in tracing the source of antimicrobial resistance in this species.
In this study, we examined the phenotypic and genotypic spectrum of antimicrobial resistance in M. morganii isolated from human and food chain animals.
Materials and methods
Bacterial strains
A total of 25 single patient isolates of M. morganii were collected for the period 2018 to 2022 from three public hospitals covering the New Territories East Region of Hong Kong. These isolates were cultured from specimens processed in the Department of Microbiology, Prince of Wales Hospital, Shatin, Hong Kong.
Blood culture was performed with a continuous monitoring blood culture system (BD BACTEC™ Blood Culture System, Becton Dickinson, NJ, USA). When flagged positive, the broth was sub-cultured onto horse blood agar (HBA) and chocolate blood agar (CBA) plates for 18–24 hours of incubation at 37°C in a 5% carbon dioxide environment. For sputum culture, the sample was inoculated to HBA and CBA for 18–24 hours of incubation at 37°C under atmospheric conditions. For urine culture, 10 µL of sample was spread on chromID CPS Elite agar (BioMérieux, Marcy-l’Étoile, France) for 18–24 hours of incubation at 37°C in atmospheric condition. For wound culture, the specimen was inoculated to HBA and CBA for 18–24 hours of incubation at 37°C in a 5% carbon dioxide environment.
The sampling method for food animals has been described before.12 In brief, 1353 food animal samples, including 182 tilapia, 314 snakehead fish, 309 black carp, heads of 187 bighead carp fish and 361 pig organs, were obtained from wet markets from all 18 districts of Hong Kong from June 2016 to September 2019. All isolates were identified by MALDI-TOF (Bruker Daltonics, Bremen, Germany).
Antibiotic susceptibility testing (AST)
Disc diffusion was performed for the following antibiotics: cefotaxime, piperacillin-tazobactam, cefepime, ertapenem, ciprofloxacin, gentamicin and amikacin. This was performed and interpreted in accordance with CLSI M100 Ed35 (2025).13
Clinical data
Clinical details of human infection cases were retrieved from electronic health records. Baseline epidemiological information and the source of infection were reviewed with ethics approval from the Joint CUHK-NTEC Clinical Research Ethics Committee (ref. no. 2020.007). Declaration of Helsinki was adhered to during this study. The requirement on patient consent was waived by the ethics board.
Whole-genome sequencing (WGS)
Whole-genome sequencing was performed as previously described.13 Briefly, bacterial DNA was extracted with Tiangen TGuide Smart Universal DNA Kit (Tiangen, Beijing, China), followed by library preparation and sequencing using the Twist 96-plex Library Prep Kit (Twist Bioscience, CA, USA) and the Nextseq 500 high-output system, according to the manufacturer’s protocol (Illumina, CA, USA). Approximately 40× average coverage of 150 bp pair-end sequence data was generated. Genomes were assembled and analysed after performing quality control as previously described.14 Sequence reads were assessed via FastQC, while low quality reads and adaptors were removed while running de novo assembly via Shovill (v.1.0.9). Quality control and contamination was speculated using Kraken2 (v.2.0.8-beta) and QUAST (v.5.0.2). Detection of antibiotic resistance genes (ARGs) and plasmid replicons were performed using ABRicate (v.1.0.1), matching with the NCBI and PlasmidFinder databases. Sequence types were determined by submitting the genomes to Bigsdb (https://bigsdb.pasteur.fr/). The phylogenetic core SNP tree was generated using Parsnp (v.1.5.3) with default settings and visualized with iTOL (v.7.0). M. morganii ATCC25830 (GenBank no. CP034944.1) was used as the reference strain. Genome assemblies were deposited to NCBI database (BioProject accession no. PRJNA1290033). We compared our strains with a Chinese study involving 60 M. morganii strains from human and animals as most of the food products from the wet markets were imported from China.14 We downloaded seven genomes from human blood specimen and animals with GenBank accession numbers listed in Table S1 (available as Supplementary data at JAC-AMR Online).
Statistical analysis
Statistical analysis was performed with R v.4.4.1 (R Core Team, 2025). Summary statistics were used for exploratory analysis. Univariable analysis of categorical variables was conducted by Fisher’s exact test. P values <0.05 were considered statistically significant.
Results
Demographics of patients
The median age of the 25 patients was 76.4 years (range 53.0–86.0). Fifteen patients were male and 10 were female. Among the 25 isolates, 22 were obtained from blood cultures and the remaining 3 isolates from urine, wound and sputum respectively. Twelve cases (48%) were polymicrobial infections. Eight (32%) isolates were recovered from patients with urinary tract infections, six (24%) with biliary tract infections, four (16%) intra-abdominal infections, three (12%) with pneumonia, three (12%) with bacteraemia without other sources and one (4%) from a patient who had a soft tissue infection. As for food animal strains, 60 M. morganii isolates were obtained from freshwater fish, whereas four were recovered from pig offals.
Phenotypic antibiotic resistance in human and food animal isolates
The percentage resistance to the tested antibiotics on human, fish and pig isolates is shown in Table 1. Phenotypic resistance to fluoroquinolones (ciprofloxacin and levofloxacin) and aminoglycosides (amikacin and gentamicin) were significantly different in the groups, with higher resistance rate in animal isolates for fluoroquinolones(P < 0.01, P = 0.03) while that for aminoglycosides was significantly higher in human isolates (P = 0.046 and P = 0.01). For beta-lactams including cefotaxime, cefepime, piperacillin-tazobactam and ertapenem, there was no statistically significant difference between the resistance rates in animal or human isolates. Only one isolate was resistant to ertapenem (CUHK_MMOR13BC_18).
Table 1.
Percentage Resistance to eight antibiotics in M. morganii from fish, pigs and human (N= 89 isolates)
| Total (n = 89) n (%) | Fish/pig (n = 64) n (%) | Human (n = 25) n (%) | P value | |
|---|---|---|---|---|
| Piperacillin-tazobactam | 11 (12.4%) | 5 (7.8%) | 6 (24%) | 0.07 |
| Cefotaxime | 12 (13.5%) | 9 (14.1%) | 3 (12%) | 1 |
| Cefepime | 4 (4.5%) | 2 (3.1%) | 2 (8%) | 0.31 |
| Ertapenem | 1 (1.1%) | 0 (0%) | 1 (4%) | 0.28 |
| Amikacin | 9 (10.1%) | 3 (4.7%) | 6 (24%) | 0.01 |
| Gentamicin | 19 (21.3%) | 10 (15.6%) | 9 (36%) | 0.046 |
| Ciprofloxacin | 71 (79.8%) | 59 (92.2%) | 12 (48%) | <0.01 |
| Levofloxacin | 46 (51.7%) | 38 (59.4%) | 8 (32%) | 0.03 |
P value was performed using Fisher’s exact test.
Genome analysis in human and food animal isolates
Table 2 summarizes the molecular characteristics of the 89 M. morganii strains showing their STs, plasmids and ARGs and conferring antibiotic resistance classes. The main ST was ST14 (7.9%, 7/89), while ST8, ST22, ST94, ST112 and ST116, each had five isolates, contributing to 5.6% of all strains).
Table 2.
Molecular characteristics of M. morganii
| Molecular characteristics | Total (n = 89) n (%) | Animal (n = 64) n (%) | Human (n = 25) n (%) | P value |
|---|---|---|---|---|
| Sequence types | ||||
| ST14 | 7 (7.9%) | 6 (9.4%) | 1 (4%) | 0.668 |
| ST8 | 5 (5.6%) | 4 (6.3%) | 1 (4%) | 1 |
| ST22 | 5 (5.6%) | 2 (3.1%) | 3 (12%) | 0.13 |
| ST94 | 5 (5.6%) | 5 (7.8%) | 0 (0%) | 0.32 |
| ST96 | 5 (5.6%) | 5 (7.8%) | 0 (0%) | 0.32 |
| ST112 | 5 (5.6%) | 5 (7.8%) | 0 (0%) | 0.32 |
| ST116 | 5 (5.6%) | 5 (7.8%) | 0 (0%) | 0.32 |
| ST21 | 4 (4.5%) | 3 (4.7%) | 1 (4%) | 1 |
| ST26 | 4 (4.5%) | 1 (1.6%) | 3 (12%) | 0.06 |
| ST118 | 4 (4.5%) | 4 (6.3%) | 0 (0%) | 0.57 |
| Other ST (n < 3) | 41 (46.1%) | 27 (42.2%) | 14 (56%) | — |
| Unknown | 3 (3.4%) | 1 (1.6%) | 2 (8%) | — |
| Plasmid present | 36 (40.4%) | 28 (43.8%) | 8 (32%) | 0.35 |
| Col3M | 33 (37.1%) | 27 (42.2%) | 6 (24%) | 0.14 |
| Col156 | 2 (2.2%) | 2 (3.1%) | 0 (0%) | 1 |
| Col(MG828) | 1 (1.1%) | 1 (1.6%) | 0 (0%) | 1 |
| ColpVC | 1 (1.1%) | 0 (0%) | 1 (4%) | 1 |
| IncQ1 | 1 (1.1%) | 0 (0%) | 1 (4%) | 1 |
| ARGs | ||||
| Aminoglycoside resistance | ||||
| aadA gene family | 40 (44.9%) | 32 (50%) | 8 (32%) | 0.16 |
| aph(3″) gene family | 27 (30.3%) | 21 (32.8%) | 6 (24%) | 0.46 |
| aac(6′) gene family | 19 (21.3%) | 16 (25%) | 3 (12%) | 0.25 |
| aac(3) gene family | 18 (20.2%) | 13 (20.3%) | 5 (20%) | 1 |
| ant(2″)-Ia | 11 (12.4%) | 9 (14.1%) | 1 (4%) | 0.27 |
| Trimethoprim resistance | ||||
| dfrA gene family | 41 (46.1%) | 32 (50%) | 9 (36%) | 0.25 |
| Beta-lactamases | ||||
| DHA gene family | 81 (91%) | 59 (92.2%) | 22 (88%) | 0.68 |
| MOR-2 | 3 (3.4%) | 2 (3.1%) | 1 (4%) | 1 |
| blaOXA-1 | 11 (12.4%) | 8 (12.5%) | 3 (12%) | 1 |
| blaOXA-10 | 8 (9%) | 8 (12.5%) | 0 (0%) | 0.1 |
| blaOXA-4 | 1 (1.1%) | 1 (1.6%) | 0 (0%) | 1 |
| blaCARB2 | 1 (1.1%) | 0 (0%) | 1 (4%) | 0.28 |
| blaVEB-1 | 1 (1.1%) | 1 (1.6%) | 0 (0%) | 1 |
| blaTEM-1 | 10 (11.2%) | 7 (10.9%) | 3 (12%) | 1 |
| blaCTX-M-3 | 3 (3.4%) | 3 (4.7%) | 0 (0%) | 0.56 |
P value was performed using Fisher’s exact test.
Thirty-six strains (40.4%) showed the presence of plasmids in their genome and were largely plasmid col3M (33/89, 37.1%). Col3M was reported to carry the qnrD1 gene, conferring resistance to quinolone.14 Most isolates from human and animals were positive for class C beta-lactamases, namely the blaDHA family (81/89, 91%), which is intrinsically resistant in M. morganii. Other types of beta-lactamase genes found were blaOXA-4 and blaCARB2 genes as well as blaOXA-1 and blaOXA-10 that confer cephalosporin resistance (11/89, 12.4% and 8/89, 9%). ARGs related to ESBL were observed for blaVEB-1 (1/89, 1.1%), blaTEM-1 (10/89, 11.2%) and blaCTX-M-3 genes (3/89, 3.4%). All three strains with blaCTX-M-3 genes were isolated from fish. Aminoglycoside-modifying enzymes, in particular the aph(3″) gene family, was found in 32.8% (n = 21/64) of fish/pig isolates and 24% (6/25) of human isolates. There was no statistical difference in ARG prevalence between human isolates and food animal isolates (Table 2, Table S2). Carbapenemase was uncommon with only one harboured blaNDM (CUHK_MMOR13BC_18), which corresponded to the ertapenem-resistant isolate in Table 1. The strain also contained ble-MBL gene, which is often noted to be in the vicinity of blaNDM conferring resistance not only to carbapenems, but also bleomycin.15
Our core-genome SNP tree showed that one strain (CUHK_MMOR13BC_18) was more distant from the other M. morganii strains (Figure 1). Five clades with a mix of human and animal strains (Clades 1–5) (Figure S1) were identified. Clade 1 belonged to ST21 (4/89, 4.5%), containing one human (4% of 25 strains), one pig and two fish strains (collectively 4.7% of 64 strains). Clade 2 was ST22 (5/89, 5.6%), which consisted of three human and two fish strains and a human strain with unknown ST. The third clade (Clade 3) was ST26 (4/89, 4.5%) and contained a mix of three human and one fish strain. ARGs was less observed in this clade compared with Clades 1 and 2. Clade 4 was largely ST14 (7/89, 7.9%), containing one human and six fish strains with a signature of aminoglycoside resistance genes [aac(3)-IId, aadA5, aph(3″)-Ib, aph(6)-Id]. The last clade, Clade 5, contained the fewest ARGs and was ST8 (four fish strains and a human strain making up to 5.6% of the 89 strains).
Figure 1.
Phylogenetic core SNP tree of 89 M. morganii from human and food animals. Coloured labels are defined in the legend. The isolation year and the presence or absence of antimicrobial resistance genes/plasmid replicons are shown.
While comparing seven human blood isolates and food animal strains from a Chinese study, we noted only three out of seven strains of M. morganii were similar and related to our strains in Clades 1 and 4.14 The human blood isolate from Guangdong (ZJF894) clustered with our study strains in Clade 1. Another pig strain from stool (171016) was closely related to Clade 4, while the human blood isolates ZJC25 and 229813 clustered with our strains in Clade 4. For a phylogenetic tree incorporating strains from our study and that of the Chinese study, please refer to Figure S2.
Discussion
To our knowledge, most of the literature focuses either on the clinical epidemiology of M. morganii or the prevalence of the species and subspecies in the environment, but has not yet brought both aspects together from a One Health perspective. Our study brings forth the issue of potential cross-host transmission by comparing genome content and AMR phenotypes in clinical and food animal strains that were isolated in a similar time period. The ability of M. morganii to acquire ARGs through mobile genetic elements when it is already intrinsically resistant to a certain number of antibiotics (AmpC) renders grave concern in One Health and AMR, especially when it is also regarded as part of the human normal flora and is ubiquitous in the environment. Despite our low number of human isolates, we selected strains with more severe infection for comparison as these strains were the more worrisome ones when compared with the non-invasive strains. Furthermore, the number of invasive infections has been almost static in Hong Kong with an average of 24–25 cases in our tertiary hospital per annum from 2018 to 2022. This number is also similar to a recent epidemiology study in Beijing where 218 clinical M. morganii isolates were assessed for the period 2016–2023 (i.e. an 8-year period).16
We noted five clades of our strains contained genomes from both animal and human strains. This indicates their similarities in genomic content where most of them belonged to certain STs (ST21, ST22, ST26, ST14 and ST8). Therefore, cross-host transmission is possible for these clades. M. morganii is conventionally considered a nosocomial pathogen arising from a healthy gut microbiome.17 This study hence calls for further investigation to understand potential routes of M. morganii infection in humans from its niche. Zoonosis has been demonstrated in non-typhoidal Salmonella, and potential zoonosis via consumption of handling of food animals was also noted in Streptococcus agalactiae ST283 and ESBL-producing Enterobacterales.12,18–20 Therefore, AMR and source of M. morganii warrants active surveillance to prevent similar infection or outbreaks in the community.
Intrinsic resistance to β-lactams, including ampicillin, penicillin, first- and second-generation cephalosporin, fosfomycin and colistin are known to M. morganii. They are generally susceptible to fourth-generation cephalosporins, carbapenems, quinolones,and trimethoprim/sulfamethoxazole. However, the carriage of ESBL genes and NDM gene in our collection of human and food animal isolates is concerning, as transmission of AMR via the food chain is well-documented across various bacteria. Fortunately, we did not observe the extensive carriage of carbapenemase genes as in the previous studies.4,9
Recently, the mobile colistin resistance (mcr) gene has also been reported in sewage and food products, highlighting the escalation of AMR in M. morganii.21 Fortunately, the mcr gene was absent in our food animal strains.
The Hong Kong Special Administrative Region, China, is a small yet densely populated area and relies on imported food products for daily consumption. As mainland China is the main import supplier for Hong Kong wet markets, from vegetables to seafood and farm animals, it made sense to compare corresponding human and animal strains reported from mainland in this regard. Whereas the mainland China animal strains were distinct from our human cohort isolates, the human strains clustered with our clades, underpinning the significance of cross-border microbial surveillance.
Further study is warranted to characterize the link between human and food animals in the setting of M. morganii. An epidemiological study on the link between food intake and M. morganii invasive infection can be done to establish the potential link between food intake and subsequent infection. Enhanced surveillance on other food, such as beef, mutton, seawater fish or vegetables, should be considered to obtain a more comprehensive view from a One Health perspective.
Conclusion
Similar to all Gram-negative bacteria, M. morganii is more than capable of acquiring antibiotic resistance via horizontal transfer of mobile genetic elements. It is ubiquitous in the environment and is part of the normal human flora. Our study has noted genome similarities in terms of AMR and other molecular characteristics of M. morganii in both food animals and human bacteraemia strains. Thus, its potential in zoonosis and role in AMR necessitates active surveillance of the bacteria before the issue escalates.
Supplementary Material
Acknowledgements
We acknowledge the support of laboratory staff in the Department of Microbiology of the Prince of Wales Hospital in this study. We also acknowledge the genome sequencing service of the Core Utilities for Cancer Genomics and Pathobiology, The Chinese University of Hong Kong.
Contributor Information
Carmen Li, Department of Microbiology, Chinese University of Hong Kong, Hong Kong (SAR), People’s Republic of China.
Lok Hang Alfred Lee, Department of Microbiology, Prince of Wales Hospital, Hong Kong (SAR), People’s Republic of China.
Dulmini Nanayakkara Sapugahawatte, Institute of Veterinary Medicine and Animal Science, Estonian University of Life Science, Tartu, Estonia.
Wing Shan Lee, Department of Microbiology, Chinese University of Hong Kong, Hong Kong (SAR), People’s Republic of China.
Ingrid Yu Ying Cheung, Department of Microbiology, Prince of Wales Hospital, Hong Kong (SAR), People’s Republic of China.
Viola Chi Ying Chow, Department of Microbiology, Prince of Wales Hospital, Hong Kong (SAR), People’s Republic of China.
Margaret Ip, Department of Microbiology, Chinese University of Hong Kong, Hong Kong (SAR), People’s Republic of China; Department of Microbiology, Prince of Wales Hospital, Hong Kong (SAR), People’s Republic of China; S. H. Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Sha Tin, Hong Kong (SAR), People’s Republic of China.
Funding
We acknowledge the funding bodies for supporting this project. This project was supported by the Food and Health Bureau, Government of Hong Kong Special Administrative Region: Commissioned Programme for Control of Infectious Diseases (no. CID-CUHK-C, PI:MI) and the Health and Medical Research Fund (HMRF no. 17106212, PI:MI). The funding bodies were not involved in the study’s design, data collection, analysis or interpretation of data or in manuscript writing.
Author contributions
Conceptualization, supervision and administration, M.I.; methodology, data retrieval and genomic analyses, A.L.H.L., C.L., W.S.L. and D.S.; laboratory sample preparation, W.S.L. and D.S. and first draft of the manuscript, A.L.H.L. and C.L. All authors contributed to critical input and editing of manuscript.
Transparency declarations
None to declare.
Supplementary data
Figures S1 and S2 and Tables S1 and S2 are available as Supplementary data at JAC-AMR Online.
References
- 1. Erlanger D, Assous MV, Wiener-Well Y et al. Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis. J Microbiol Immunol Infect 2019; 52: 443–8. 10.1016/j.jmii.2017.08.010 [DOI] [PubMed] [Google Scholar]
- 2. Laupland KB, Paterson DL, Edwards F et al. Morganella morganii, an emerging cause of bloodstream infections. Microbiol Spectr 2022; 10: e0056922. 10.1128/spectrum.00569-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Lin TY, Chan MC, Yang YS et al. Clinical manifestations and prognostic factors of Morganella morganii bacteremia. Eur J Clin Microbiol Infect Dis 2015; 34: 231–6. 10.1007/s10096-014-2222-8 [DOI] [PubMed] [Google Scholar]
- 4. Bonnin RA, Creton E, Perrin A et al. Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study. Lancet Microbe 2024; 5: e547–58. 10.1016/S2666-5247(23)00407-X [DOI] [PubMed] [Google Scholar]
- 5. Li X, Yao J, Zhou L et al. Endemicity and diversification of Morganella spp and carbapenemase-producing Morganella spp. Lancet Microbe 2024; 5: 100970. 10.1016/j.lanmic.2024.100970 [DOI] [PubMed] [Google Scholar]
- 6. Munir A, Lv Y, Song R et al. Emergence of carbapenem resistant Escherichia coli, Morganella morganii, Providencia rettgeri harboring bla(NDM) genes in minks from China. Vet Microbiol 2025; 307: 110585. 10.1016/j.vetmic.2025.110585 [DOI] [PubMed] [Google Scholar]
- 7. Sabtcheva S, Stoikov I, Ivanov IN et al. Genomic characterization of carbapenemase-producing Enterobacter hormaechei, Serratia marcescens, Citrobacter freundii, Providencia stuartii, and Morganella morganii Clinical Isolates from Bulgaria. Antibiotics 2024; 13: 455. 10.3390/antibiotics13050455 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Xiang G, Lan K, Cai Y et al. Clinical molecular and genomic epidemiology of Morganella morganii in China. Front Microbiol 2021; 12: 744291. 10.3389/fmicb.2021.744291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Yao J, Hu Y, Wang X et al. Carbapenem-resistant Morganella morganii carrying bla(KPC-2) or bla(NDM-1) in the clinic: one-decade genomic epidemiology analysis. Microbiol Spectr 2025; 13: e0247624. 10.1128/spectrum.02476-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Siddiqui R, Boghossian A, Akbar N et al. A One Health approach versus Acanthamoeba castellanii, a potential host for Morganella morganii. Int Microbiol 2022; 25: 781–8. 10.1007/s10123-022-00261-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. McEwen SA, Collignon PJ. Antimicrobial resistance: a One Health perspective. Microbiol Spectr 2018; 6(2): 10.1128. 10.1128/microbiolspec.ARBA-0009-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Sapugahawatte DN, Li C, Zhu C et al. Prevalence and characteristics of extended-spectrum-beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae from freshwater fish and pork in wet markets of Hong Kong. mSphere 2020; 5: e00107-20. 10.1128/mSphere.00107-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. CLSI . Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, 2025. 35th ed. CLSI supplement M100. [Google Scholar]
- 14. Jing Y, Yin Z, Wang P et al. A genomic and bioinformatics view of the classification and evolution of Morganella species and their chromosomal accessory genetic elements harboring antimicrobial resistance genes. Microbiol Spectr 2022; 10: e0265021. 10.1128/spectrum.02650-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Dortet L, Girlich D, Virlouvet AL et al. Characterization of BRP(MBL), the bleomycin resistance protein associated with the carbapenemase NDM. Antimicrob Agents Chemother 2017; 61(3): e02413–e02416. 10.1128/AAC.02413-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Zhu W, Liu Q, Liu J et al. Genomic epidemiology and antimicrobial resistance of Morganella clinical isolates between 2016 and 2023. Front Cell Infect Microbiol 2025; 14: 1464736. 10.3389/fcimb.2024.1464736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000; 13: 534–46. 10.1128/CMR.13.4.534 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Woh PY, Yeung MPS, Goggins WB III et al. Genomic epidemiology of multidrug-resistant nontyphoidal Salmonella in young children hospitalized for gastroenteritis. Microbiol Spectr 2021; 9: e0024821. 10.1128/Spectrum.00248-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Li C, Tse H, Zhu C et al. Invasive group B Streptococcus infections caused by hypervirulent clone of S. agalactiae sequence type 283, Hong Kong, China, 2021(1). Emerg Infect Dis 2025; 31: 149–54. 10.3201/eid3101.231627 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Li C, Sapugahawatte DN, Yang Y et al. Multidrug-resistant Streptococcus agalactiae strains found in human and fish with high penicillin and cefotaxime non-susceptibilities. Microorganisms 2020; 8: 1055. 10.3390/microorganisms8071055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Hassan J, Mann D, Li S et al. First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA. J Glob Antimicrob Resist 2022; 29: 540–1. 10.1016/j.jgar.2021.11.013 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

